Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice

Molecular Neurodegeneration

Volumn 9, Issue 1, 2014, Pages

  Herdewyn, Sarah ^a,b,c   Cirillo, Carla ^d   Van Den Bosch, Ludo ^a,b   Robberecht, Wim ^a,b,c   Vanden Berghe, Pieter ^d   Van Damme, Philip ^a,b,c  

^a KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

ALS; Enteric nervous system; Gastro intestinal tract; Neurodegeneration; TDP43

Indexed keywords

MESSENGER RNA; NITRIC OXIDE SYNTHASE; TAR DNA BINDING PROTEIN; DNA BINDING PROTEIN; TDP-43 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIET; DISEASE COURSE; DOWN REGULATION; EX VIVO STUDY; FEMALE; FIBER; FOOD; GEL; IMMUNOHISTOCHEMISTRY; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE OBSTRUCTION; MALE; MOUSE; MYENTERIC PLEXUS; NERVE CELL; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; PHENOTYPE; SEX DIFFERENCE; SUDDEN DEATH; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; GASTROINTESTINAL MOTILITY; GENETICS; INTESTINAL OBSTRUCTION; MOTONEURON; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GASTROINTESTINAL MOTILITY; INTESTINAL OBSTRUCTION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; MYENTERIC PLEXUS; NERVE DEGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84902300616     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-9-24     Document Type: Article

References (37)

1. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM, Science 2006 314 130 133 (Pubitemid 44547757)
2. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW, Ann Neurol 2007 61 435 445 (Pubitemid 46878771)
3. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Hasegawa M, Arai T, Akiyama H, Nonaka T, Mori H, Hashimoto T, Yamazaki M, Oyanagi K, Brain 2007 130 1386 1394 (Pubitemid 47355958)
4. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL, J Neuropathol Exp Neurol 2008 67 1159 1165 doi:10.1097/NEN. 0b013e31818e8951
5. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Lee EB, Lee VM, Trojanowski JQ, Nat Rev Neurosci 2012 13 38 50 doi:10.1038/nrn3121
6. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N, Rouleau GA, Nat Genet 2008 40 572 574 doi:10.1038/ng.132 (Pubitemid 351601218)
7. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, De Belleroche J, Mitchell JD, Leigh PN, Al-Chalabi A, Miller CC, Nicholson G, Shaw CE, Science 2008 319 1668 1672 doi:10.1126/science.1154584 (Pubitemid 351432505)
8. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM, Chen-Plotkin AS, Martinez-Lage M, Steinbart E, McCluskey L, Grossman M, Neumann M, Wu IL, Yang WS, Kalb R, Galasko DR, Montine TJ, Trojanowski JQ, Lee VM, Schellenberg GD, Yu CE, Lancet Neurol 2008 7 409 416 doi:10.1016/S1474-4422(08)70071-1
9. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz HB, McAlonis-Downes M, Platoshyn O, Parone PA, Da Cruz S, Clutario KM, Swing D, Tessarollo L, Marsala M, Shaw CE, Yeo GW, Cleveland DW, Proc Natl Acad Sci U S A 2013 110 736 E745 doi:10.1073/pnas.1222809110
10. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T, Malunda J, Xu Y, Winton MJ, Trojanowski JQ, Lee VM, J Clin Invest 2011 121 726 738 doi:10.1172/JCI44867
11. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Shan X, Chiang PM, Price DL, Wong PC, Proc Natl Acad Sci U S A 2010 107 16325 16330 doi:10.1073/pnas.1003459107
12. Progressive motor weakness in transgenic mice expressing human TDP-43. Stallings NR, Puttaparthi K, Luther CM, Burns DK, Elliott JL, Neurobiol Dis 2010 40 404 414 doi:10.1016/j.nbd.2010.06.017
13. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Swarup V, Phaneuf D, Bareil C, Robertson J, Rouleau GA, Kriz J, Julien JP, Brain 2011 134 2610 2626 doi:10.1093/brain/awr159
14. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. Tsai KJ, Yang CH, Fang YH, Cho KH, Chien WL, Wang WT, Wu TW, Lin CP, Fu WM, Shen CK, J Exp Med 2010 207 1661 1673 doi:10.1084/jem.20092164
15. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH, Proc Natl Acad Sci U S A 2009 106 18809 18814 doi:10.1073/pnas.0908767106
16. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick-de Groote C, Van Broeckhoven C, Kumar-Singh S, Proc Natl Acad Sci U S A 2010 107 3858 3863 doi:10.1073/pnas.0912417107
17. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, Casey MC, Tong J, Knight J, Yu X, Rademakers R, Boylan K, Hutton M, McGowan E, Dickson DW, Lewis J, Petrucelli L, J Neurosci 2010 30 10851 10859 doi:10.1523/JNEUROSCI.1630-10. 2010
18. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Xu YF, Zhang YJ, Lin WL, Cao X, Stetler C, Dickson DW, Lewis J, Petrucelli L, Mol Neurodegener 2011 6 73 doi:10.1186/1750-1326-6-73
19. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Esmaeili MA, Panahi M, Yadav S, Hennings L, Kiaei M, Int J Exp Pathol 2013 94 56 64 doi:10.1111/iep.12006
20. HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Guo Y, Wang Q, Zhang K, An T, Shi P, Li Z, Duan W, Li C, Brain Res 2012 1460 88 95 doi:10.1016/j.brainres.2012.04.003
21. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice. Medina DX, Orr ME, Oddo S, Neurobiol Aging 2014 35 79 87 doi:10.1016/j.neurobiolaging.2013.07.006
22. Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Tsuji H, Nonaka T, Yamashita M, Masuda-Suzukake M, Kametani F, Akiyama H, Mann DM, Tamaoka A, Hasegawa M, Biochem Biophys Res Commun 2012 417 116 121 doi:10.1016/j.bbrc.2011.11.066
23. TDP-43 regulates its mRNA levels through a negative feedback loop. Ayala YM, De Conti L, Avendaño-Vázquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E, Baralle FE, EMBO J 2011 30 277 288 doi:10.1038/emboj.2010.310
24. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett CF, Yeo GW, Cleveland DW, Nat Neurosci 2011 14 459 468 doi:10.1038/nn.2779
25. The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43. Xu YF, Prudencio M, Hubbard JM, Tong J, Whitelaw EC, Jansen-West K, Stetler C, Cao X, Song J, Zhang YJ, PLoS One 2013 8 69864 doi:10.1371/journal.pone.0069864
26. Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor. Prudencio M, Jansen-West KR, Lee WC, Gendron TF, Zhang YJ, Xu YF, Gass J, Stuani C, Stetler C, Rademakers R, Dickson DW, Buratti E, Petrucelli L, Proc Natl Acad Sci U S A 2012 109 21510 21515 doi:10.1073/pnas.1211577110
27. The dorsolateral corticospinal tract in mice: an alternative route for corticospinal input to caudal segments following dorsal column lesions. Steward O, Zheng B, Ho C, Anderson K, Tessier-Lavigne M, J Comp Neurol 2004 472 463 477 (Pubitemid 38508830)
28. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine. Albanese V, Lawson VA, Hill AF, Cappai R, Di Guardo G, Staikopoulos V, Thacker M, Furness JB, Chiocchetti R, Auton Neurosci 2008 140 17 23 doi:10.1016/j.autneu.2008.01.008
29. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Hatzipetros T, Bogdanik LP, Tassinari VR, Kidd JD, Moreno AJ, Davis C, Osborne M, Austin A, Vieira FG, Lutz C, Perrin S, Brain Res 2013 doi:10.1016/j.brainres.2013.10.013
30. Parallel manifestations of neuropathologies in the enteric and central nervous systems. Natale G, Pasquali L, Paparelli A, Fornai F, Neurogastroenterol Motil 2011 23 1056 1065 doi:10.1111/j.1365-2982.2011.01794.x
31. Visceral neuropathy and intestinal pseudo-obstruction in a murine model of a nuclear inclusion disease. Clarke CM, Plata C, Cole B, Tsuchiya K, La Spada AR, Kapur RP, Gastroenterology 2007 133 1971 1978 (Pubitemid 350180799)
32. Nerve activity recordings in routine human intestinal biopsies. Cirillo C, Tack J, Vanden Berghe P, Gut 2013 62 227 235 doi:10.1136/gutjnl-2011-301777
33. Planar cell polarity genes control the connectivity of enteric neurons. Sasselli V, Boesmans W, Vanden Berghe P, Tissir F, Goffinet AM, Pachnis V, J Clin Invest 2013 123 1763 1772 doi:10.1172/JCI66759
34. Quantitative analysis of peristalsis in the guinea-pig small intestine using spatio-temporal maps. Hennig GW, Costa M, Chen BN, Brookes SJ, J Physiol 1999 517 575 590 (Pubitemid 29296370)
35. Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats. Herdewyn S, De Muynck L, Van Den Bosch L, Robberecht W, Van Damme P, Neurobiol Aging 2013 34 2302 2303 doi:10.1016/j.neurobiolaging.2013.03.027
36. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Taes I, Timmers M, Hersmus N, Bento-Abreu A, Van Den Bosch L, Van Damme P, Auwerx J, Robberecht W, Hum Mol Genet 2013 22 1783 1790 doi:10.1093/hmg/ddt028
37. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, Peeters E, Philips T, Goris A, Dubois B, Andersen PM, Al-Chalabi A, Thijs V, Turnley AM, Van Vught PW, Veldink JH, Hardiman O, Van Den Bosch L, Gonzalez-Perez P, Van Damme P, Brown RH Jr, van den Berg LH, Robberecht W, Nat Med 2012 18 1418 1422